Clinicopathological Characterization of Squamous Cell Lung Carcinoma Adjacent to Emphysema
Pathology International · 2025
DOI: 10.1111/pin.70023 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pathology International, 2025. Verfasst von Tetsuya Sakai und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology and Clinical Laboratories, National Cancer Center Hospital East, Kashiwa, Japan. Hauptthemen laut MEDLINE: Lung Neoplasms, Carcinoma, Squamous Cell, Pulmonary Emphysema, Emphysema. Die Arbeit nennt 36 Literaturangaben.
Abstract (Originalsprache)
The study investigated the clinicopathological features and characteristic immune tumor microenvironment (TME) of lung squamous cell carcinoma (SqCC) adjacent to emphysematous lesions. 184 consecutive patients with peripheral‐type SqCC who had undergone complete surgical resection were enrolled. The clinicopathological differences between emphysema‐adjacent SqCC (EA‐SqCC) and non‐emphysema‐adjacent SqCC (non‐EA‐SqCC) were examined. The immune TME, including tumor‐infiltrating lymphocytes (TILs) and PD‐L1 expression, was also analyzed. EA‐SqCC was detected in 132 (71.7%) of the 184 patients. Patients with EA‐SqCC had shorter recurrence‐free survival (RFS) [median 58.2 months vs. not Reached (NR); hazard ratio (HR) 0.47; 95% CI 0.25–0.81, p < 0.01] and tended to have shorter overall survival (NR vs. NR; HR 0.47; 95% CI 0.27–1.03, p = 0.07) compared to patients with non‐EA‐SqCC. Evaluation of TILs in the cancer stroma showed the number of Foxp3+ TILs in the EA‐SqCC group was significantly higher than that in the non‐EA‐SqCC group (median number 58 vs. 43, p < 0.01). However, there were no significant differences in the number of CD8 + T cells and the PD‐L1 expression between the two groups. Immunosuppressive microenvironment is a characteristic feature of EA‐SqCC, which may contribute to the poor prognosis of this disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology and Clinical Laboratories, National Cancer Center Hospital East, Kashiwa, Japan.
- Department of Thoracic Oncology, National Cancer Center Hospital East, Kashiwa, Japan.
- Department of Thoracic Surgery, National Cancer Center Hospital East, Kashiwa, Chiba, Japan.
- Division of Innovative Pathology and Laboratory Medicine, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center, Kashiwa, Japan.
ORCID-Profile: Genichiro Ishii
Zitieren
APA
Sakai, T., Udagawa, H., Izumi, H., Umemura, S., Zenke, Y., Matsumoto, S., Yoh, K., Tomoyuki, N., Tokiko, N., Taki, T., Sakamoto, N., Sakashita, S., Kojima, M., Tsuboi, M., Goto, K., & Ishii, G. (2025). Clinicopathological Characterization of Squamous Cell Lung Carcinoma Adjacent to Emphysema. Pathology International. https://doi.org/10.1111/pin.70023
Vancouver
Sakai T, Udagawa H, Izumi H, Umemura S, Zenke Y, Matsumoto S, et al. Clinicopathological Characterization of Squamous Cell Lung Carcinoma Adjacent to Emphysema. Pathology International. 2025. doi:10.1111/pin.70023
BibTeX
@article{Sakai2025,
author = {Sakai, Tetsuya and Udagawa, Hibiki and Izumi, Hiroki and Umemura, Shigeki and Zenke, Yoshitaka and Matsumoto, Shingo and Yoh, Kiyotaka and Tomoyuki, Naito and Tokiko, Nakai and Taki, Tetsuro and Sakamoto, Naoya and Sakashita, Shingo and Kojima, Motohiro and Tsuboi, Masahiro and Goto, Koichi and Ishii, Genichiro},
title = {Clinicopathological Characterization of Squamous Cell Lung Carcinoma Adjacent to Emphysema},
journal = {Pathology International},
year = {2025},
doi = {10.1111/pin.70023}
}
EUVIMED